Medicines for Ebola virus disease
WHO Essential Medicine EML section: Medicines for Ebola virus disease
Label status: label not available in our sources
This is information only, not a prescription. Talk to a doctor or pharmacist before taking any medicine. For an overdose or poisoning, call 102.
Atoltivimab/maftivimab/odesivimab is an essential medicine on the World Health Organization's Model List, specifically for use in the treatment of Ebola virus disease. However, a product label is not available in our sources, making it unclear how this medicine is administered or its full scope of use. This information is crucial for healthcare providers to understand and use effectively in treating Ebola cases.
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
Listed for: Medicines for Ebola virus disease (WHO EML section heading).
For a suspected overdose or poisoning, call 102 now and go to the nearest emergency hospital.
Call 102What is Atoltivimab/maftivimab/odesivimab used for?
It is listed for: Medicines for Ebola virus disease (WHO Model List section).
Is Atoltivimab/maftivimab/odesivimab an essential medicine?
Yes, it is on the WHO Model List of Essential Medicines.
What is the dose of Atoltivimab/maftivimab/odesivimab?
Not provided here. Ask a doctor or pharmacist.
What is Atoltivimab/maftivimab/odesivimab?
Atoltivimab/maftivimab/odesivimab is an essential medicine on the WHO Model List, listed under: Medicines for Ebola virus disease. A product label is not available in our sources.
Sources: WHO Model List of Essential Medicines, 23rd list (2023) · Reference · Reference
WHO Model List of Essential Medicines, 23rd list (2023), World Health Organization